Calidi Biotherapeutics CLDI

Calidi Biotherapeutics: signs a material agreement, ends a material agreement and takes on a new financial obligation

Form
8-K
Filed
Importance
Routine
  • Signs a material agreement (1.01)
  • Ends a material agreement (1.02)
  • Takes on a new financial obligation (2.03)

Not explained yet; the original is on EDGAR.

Get an email when Calidi Biotherapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.